Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
ReShape Lifesciences Community
NasdaqCM:RSLS Community
0
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
ReShape Lifesciences
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
RSLS
RSLS
ReShape Lifesciences
Your Fair Value
US$
Current Price
US$2.24
83.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-74m
15m
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.9m
Earnings US$548.4k
Advanced
Set Fair Value
